NEW YORK (GenomeWeb) – Bionano Genomics on Wednesday lowered the size of its proposed IPO, according to a filing with the US Securities and Exchange Commission.

The San Diego-based genomic research tools company plans to offer 2,450,000 units, each consisting of one share of common stock and one warrant to purchase a share of common stock, at a price of $6.00 to $7.00 per unit.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.